Odorici, Giulia
Dettaglio
Odorici, Giulia
Pubblicazioni
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Chronic kidney disease in psoriasis: a cohort study | 2020 | Conti, Andrea; Giovannini, Lisa; Mandel, Victor Desmond; Odorici, Giulia; Lasagni, Claudia; Bigi, Laura; Pellacani, Giovanni; Cappelli, Gianni |
2 | Chronische Nierenerkrankung bei Psoriasis: eine Kohortenstudie | 2020 | Conti, Andrea; Giovannini, Lisa; Mandel, Victor Desmond; Odorici, Giulia; Lasagni, Claudia; Bigi, Laura; Pellacani, Giovanni; Cappelli, Gianni |
3 | Clinical features and in vivo reflectance confocal microscopy of an atypical presentation of Herpesvirus-2 and Cytomegalovirus co-infection of the intergluteal sulcus | 2017 | Odorici, Giulia; Mandel, Victor Desmond; Giannetti, Alberto; Pellacani, Giovanni; Conti, Andrea |
4 | Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis | 2020 | Di Tullio, Francesca; Odorici, Giulia; Lasagni, Claudia; Capobianco, Marco; Conti, Andrea; Mandel, Victor Desmond |
5 | Combining secukinumab with dimethyl fumarate for treatment of a patient with psoriasis and recent diagnosis of multiple sclerosis | 2020 | Di Tullio, Francesca; Odorici, Giulia; Lasagni, Claudia; Capobianco, Marco; Conti, Andrea; Mandel, Victor Desmond |
6 | Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: a systematic review of the literature | 2021 | Lai, M.; Pampena, R.; Cornacchia, L.; Odorici, G.; Piccerillo, A.; Pellacani, G.; Peris, K.; Longo, C. |
7 | Efficacy of ustekinumab after failure of infliximab CT-P13 in a HLA-Cw6-positive patient affected by pityriasis rubra pilaris: monitoring with reflectance confocal microscopy (RCM) and optical coherence tomography (OCT) | 2017 | Paganelli, Alessia; Ciardo, S.; Odorici, G.; Pellacani, G.; Conti, A. |
8 | Evaluation of generalized pustular psoriasis by reflectance confocal microscopy | 2019 | Peccerillo, F.; Odorici, G.; Ciardo, S.; Conti, A.; Pellacani, G. |
9 | Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis | 2021 | Tarentini, Elisabetta; Odorici, Giulia; Righi, Valeria; Paganelli, Alessia; Giacomelli, Luca; Mirisola, Valentina; Mucci, Adele; Benassi, Luisa; D’Aversa, Elisabetta; Lasagni, Claudia; Kaleci, Shaniko; Reali, Eva; Magnoni, Cristina |
10 | Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting | 2017 | Conti, Andrea; Piaserico, Stefano; Gisondi, Paolo; Odorici, Giulia; Galdo, Giovanna; Lasagni, Claudia; Pellacani, Giovanni |
11 | Moderate to severe psoriasis: A single-center analysis of gender prevalence | 2021 | Odorici, G.; Paganelli, A.; Peccerillo, F.; Serra, J.; Chester, J.; Kaleci, S.; Pellacani, G.; Conti, A. |
12 | Non-invasive evaluation of Secukinumab efficacy in severe plaque psoriasis with confocal microscopy and optical coherence tomography: A case report | 2018 | Odorici, G.; Losi, A.; Ciardo, S.; Pellacani, G.; Conti, A. |
13 | Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-centre experience | 2019 | Odorici, G.; Di Lernia, V.; Bardazzi, F.; Magnano, Massimiliano; Di Nuzzo, S.; Cortelazzi, Chiara; Lasagni, C.; Bigi, L.; Corazza, M.; Pellacani, G.; Conti, A. |
14 | A real-life experience of psoriatic patients with history of cancer treated with biological drugs | 2019 | Odorici, G.; Lasagni, C.; Bigi, L.; Pellacani, G.; Conti, A. |
15 | Secukinumab: A positive outcome in a patient with severe psoriasis and HBV-HCV co-infection | 2018 | Peccerillo, F.; Odorici, G.; Pellacani, G.; Conti, A. |
16 | An unusual presentation of primary cutaneous cryptococcosis | 2019 | Longhitano, S.; Peccerillo, F.; Odorici, G.; Bigi, L.; Pellacani, G. |